Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies

被引:129
作者
Song, Y. W. [1 ]
Kang, E. H. [1 ]
机构
[1] Seoul Natl Univ, Med Res Ctr, Dept Internal Med, Div Rheumatol, Seoul, South Korea
关键词
CYCLIC CITRULLINATED PEPTIDE; HLA-DRB1 SHARED EPITOPE; MAJOR HISTOCOMPATIBILITY COMPLEX; EXTRAARTICULAR MANIFESTATIONS; ANTIFILAGGRIN AUTOANTIBODIES; ANTIKERATIN ANTIBODIES; CCP ANTIBODIES; RISK-FACTOR; B-CELLS; ASSOCIATION;
D O I
10.1093/qjmed/hcp165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease, characterized by chronic, erosive polyarthritis and by the presence of various autoantibodies in serum and synovial fluid. Since rheumatoid factor (RF) was first described, a number of other autoantibodies have been discovered in RA patients. The autoantigens recognized by these autoantibodies include cartilage components, chaperones, enzymes, nuclear proteins and citrullinated proteins. However, the clinical significances and pathogenic roles of these antibodies are largely unknown except for RF and anticitrullinated protein antibodies (ACPAs), whose clinical usefulness has been acknowledged due to their acceptable sensitivities and specificities, and prognostic values. This review presents and discusses the current state of the art regarding RF and ACPA in RA.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 82 条
[1]  
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[2]   Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review [J].
Avouac, J. ;
Gossec, L. ;
Dougados, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) :845-851
[3]   Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset [J].
Berglin, E ;
Johansson, T ;
Sundin, U ;
Jidell, E ;
Wadell, G ;
Hallmans, G ;
Rantapää-Dahlqvist, S .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) :453-458
[4]   A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis [J].
Berglin, E ;
Padyukov, L ;
Sundin, U ;
Hallmans, G ;
Stenlund, H ;
van Venrooij, WJ ;
Klareskog, L ;
Dahlqvist, SR .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) :R303-R308
[5]  
Bläss S, 1999, ARTHRITIS RHEUM, V42, P2499, DOI 10.1002/1529-0131(199912)42:12<2499::AID-ANR1>3.0.CO
[6]  
2-R
[7]   EXAMINATION OF HLA-DR4 AS A SEVERITY MARKER FOR RHEUMATOID-ARTHRITIS IN GREEK PATIENTS [J].
BOKI, KA ;
DROSOS, AA ;
TZIOUFAS, AG ;
LANCHBURY, JS ;
PANAYI, GS ;
MOUTSOPOULOS, HM .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (07) :517-519
[8]   Citrullination in extra-articular manifestations of rheumatoid arthritis [J].
Bongartz, T. ;
Cantaert, T. ;
Atkins, S. R. ;
Harle, P. ;
Myers, J. L. ;
Turesson, C. ;
Ryu, J. H. ;
Baeten, D. ;
Matteson, E. L. .
RHEUMATOLOGY, 2007, 46 (01) :70-75
[9]   Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage [J].
Borretzen, M ;
Chapman, C ;
Natvig, JB ;
Thompson, KM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (03) :735-741
[10]  
Bos WH, 2008, J RHEUMATOL, V35, P1972